| Current Price | $66.61 | Mkt Cap | $83.5B |
|---|---|---|---|
| Open | $67.00 | P/E Ratio | 277.84 |
| Prev. Close | $66.61 | Div. (Yield) | $2.84 (4.3%) |
| Daily Range | $65.89 - $67.18 | Volume | 11,464,711 |
| 52-Wk Range | $56.56 - $78.94 | Avg. Daily Vol. | 7,509,427 |
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
| Current Price | $66.61 | Mkt Cap | $83.5B |
|---|---|---|---|
| Open | $67.00 | P/E Ratio | 277.84 |
| Prev. Close | $66.61 | Div. (Yield) | $2.84 (4.3%) |
| Daily Range | $65.89 - $67.18 | Volume | 11,464,711 |
| 52-Wk Range | $56.56 - $78.94 | Avg. Daily Vol. | 7,509,427 |
The best Bull and Bear pitches based on recency and number of recommendations.
This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.
I have a real hard time imagining that Gilead will have sold enough Remdesivir to make this stock a market performer much less a market *beater.* I do continue to own shares in my real portfolio though, so I'm happy to be proven wrong. Underperform.
Read the most recent pitches from players about GILD.
Recs
TMFjimhalley
(61.52)
Submitted: 4/16/2021 11:47:44 PM :
Start Price:
$65.34
NASDAQ:GILD Score:
+2.27
Despite declining HIV drug sales, the company's growing oncology pipeline will help it increase revenue.
Recs
tomfoolme
(61.45)
Submitted: 4/11/2021 11:31:44 PM :
Start Price:
$64.15
NASDAQ:GILD Score:
+2.84
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
82B. FPE:9 div:4.4. For the div.
Recs
Dividends500
(83.11)
Submitted: 12/31/2020 11:37:12 PM :
Start Price:
$57.41
NASDAQ:GILD Score:
+5.47
Dividends500 tracks the healthiest dividends in the S&P 500.
To qualify for the portfolio, the company must meet three simple requirements:
- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year
Find the members with the highest scoring picks in GILD.
BrianMotleyFool (74.34) Score: +536.73
The Score Leader is the player with the highest score across all their picks in GILD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| WilliamCrook2003 | 71.29 |
|
|
5Y | $12.98 | +413.04% | +209.73% | +203.31 | 1 Comment | |
| UrineLuck73 | < 20 | 1/29/2007 |
|
NS | $12.98 | +413.04% | +209.73% | +203.31 | 0 Comment | |
| predragj | 41.85 | 1/30/2007 |
|
NS | $13.15 | +406.54% | +209.38% | +197.16 | 0 Comment | |
| mxdfool | < 20 | 12/15/2006 |
|
5Y | $13.21 | +404.22% | +208.31% | +195.91 | 0 Comment | |
| betsypurcell | < 20 | 1/24/2007 |
|
NS | $13.23 | +403.53% | +208.04% | +195.49 | 0 Comment | |
| JSergeant | 76.60 | 7/3/2006 |
|
3Y | $12.30 | +441.75% | +246.88% | +194.87 | 0 Comment | |
| rmarinchek | < 20 | 1/25/2007 |
|
3W | $13.33 | +399.75% | +206.17% | +193.58 | 0 Comment | |
| Redskins2k9 | < 20 | 1/25/2007 |
|
5Y | $13.33 | +399.75% | +206.17% | +193.58 | 0 Comment | |
| opveiby | 78.62 | 1/25/2007 |
|
5Y | $13.33 | +399.75% | +206.17% | +193.58 | 0 Comment | |
| jer8899 | 68.68 | 1/23/2007 |
|
NS | $13.30 | +400.84% | +208.08% | +192.77 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
